Require strong identity verification for both clinicians and patients, enforce session controls, and keep communication channels encrypted in transit and, where feasible, at rest
Bottom line The FDA strongly recommends using an FDA-approved semaglutide drug like Ozempic when it is available instead of compounded semaglutide
The main risks include gastrointestinal side effects such as nausea, constipation, and abdominal pain that may be difficult to distinguish from diverticulitis symptoms
Current evidence does not support a need for dose adjustment in coadministration of digoxin and GLP1RAs
ADR: IPSEY) Ipsen SA (Euronext: IPN
Individuals without insurance coverage may still obtain GLP-1 medications through direct-purchase channels, but cost remains a barrier for many